Cargando…
Mutant p53 as a guardian of the cancer cell
Forty years of research have established that the p53 tumor suppressor provides a major barrier to neoplastic transformation and tumor progression by its unique ability to act as an extremely sensitive collector of stress inputs, and to coordinate a complex framework of diverse effector pathways and...
Autores principales: | Mantovani, Fiamma, Collavin, Licio, Del Sal, Giannino |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329812/ https://www.ncbi.nlm.nih.gov/pubmed/30538286 http://dx.doi.org/10.1038/s41418-018-0246-9 |
Ejemplares similares
-
The rebel angel: mutant p53 as the driving oncogene in breast cancer
por: Walerych, Dawid, et al.
Publicado: (2012) -
Complexes formed by mutant p53 and their roles in breast cancer
por: Bellazzo, Arianna, et al.
Publicado: (2018) -
Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
por: Capaci, Valeria, et al.
Publicado: (2021) -
p73 as a Pharmaceutical Target for Cancer Therapy
por: Bisso, Andrea, et al.
Publicado: (2011) -
A mutant p53/Hif1α/miR-30d axis reprograms the secretory pathway promoting the release of a prometastatic secretome
por: Capaci, Valeria, et al.
Publicado: (2020)